Helicase-primase as a target of new therapies for herpes simplex virus infections.
about
Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymeraseClinical Pharmacology & Therapeutics: the next five years.Production and characterisation of Epstein-Barr virus helicase-primase complex and its accessory protein BBLF2/3.Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study.The Human Replicative Helicase, the CMG Complex, as a Target for Anti-cancer Therapy.
P2860
Helicase-primase as a target of new therapies for herpes simplex virus infections.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Helicase-primase as a target of new therapies for herpes simplex virus infections.
@en
type
label
Helicase-primase as a target of new therapies for herpes simplex virus infections.
@en
prefLabel
Helicase-primase as a target of new therapies for herpes simplex virus infections.
@en
P2093
P2860
P356
P1476
Helicase-primase as a target of new therapies for herpes simplex virus infections
@en
P2093
P2860
P356
10.1002/CPT.3
P407
P577
2014-11-18T00:00:00Z